ZEVRA THERAPEUTICS INCZVRA
ASignal's systematic analysis rates ZVRA as Neutral.
Reflects the latest available analysis · analyzed Sep 30, 2026
The case on ZVRA
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong free cash flow of $48.38M
- Exceptional gross margin of 95.46%
- High return on equity at 34.80%
- Very low debt-to-equity ratio of 0.01x
- RSI at 26.52 indicates potential oversold rebound
- Cash-rich balance sheet with $221.57M in cash vs $1.50M debt
- Negative price momentum (-0.0697)
- MACD below signal line with negative histogram
- Earnings growth YoY at -88.40%
- No Reddit mentions, suggesting low retail interest
- PEG ratio elevated at 10.67x, indicating potential overvaluation relative to growth
See the full verdict on ZVRA
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ZVRA
Most investors never get a second opinion, let alone several. ASignal runs ZVRA past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.